Zydus's ''fingerprint match'' Humira version debuts in India
This article was originally published in Scrip
Executive Summary
Zydus Cadila has launched the first ever biosimilar version of AbbVie's blockbuster biologic, Humira (adalimumab), in India at a fraction of the innovator product price.